Advertisement

Topics

Biotech jobs - Biotech, Pharma and Life Science Channel

09:52 EDT 18th June 2018 | BioPortfolio

News Articles [416 Associated News Articles listed on BioPortfolio]

Acticor Biotech Confirms Simbec-Orion to Make Its First in Patient Study in Acute Ischemic Stroke

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and pulmonary embolism, as part of the development of ...

PharmaCyte Biotech Successfully Completes Another FDA Required Study Necessary for Submitting Investigational New Drug Application

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature...

Dirk Kersten Joins Forbion as General Partner

Forbion, one of the leading European life science venture capital firms, today announces that Dirk Kersten will join as a General Partner on October 1st, 2018. Dir...

JHL Biotech Announces Completion of Convertible Bond Issuance and Appointment of New Chief Financial Officer

HSINCHU and WUHAN, June 14, 2018 /PRNewswire/ -- JHL Biotech has raised US$106 million in a convertible bond issuance, which closed May 15, 2018. Proceeds raised from the issuan...

Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation

    Siemens becomes a preferred supplier for automation solutions Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future...

FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06

FIT Biotech Oy  Company release 12.6.2018 at 8:30 AM EET First EHVA clinical trial authorization granted for testing FIT-06 FIT Biotech Oy ("Company", FITBIO: FN Finland) ...

Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board

Vivet Therapeutics, a biotechnology company developing novel gene therapies for rare, inherited metabolic diseases today announced the appointment of Eduardo Bravo as Chairman of ...

Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors

SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addiction...

Sinovac Biotech Relaunches Company Website

BEIJING, June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today a...

Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab

BERKELEY, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced the recent initiation of a Phase 1b study of ADU-214 (JNJ-64041757) in combination with nivolum...

Events [0 Results]

None

Companies [244 Associated Companies listed on BioPortfolio]

Seed 2 Growth Ventures

Seed was founded to pioneer the application of microbiome science to improve human and planetary health. In collaboration with leading scientists and a global network of partners ...

Coalition of State Bioscience Institutes (CSBI)

The Coalition for State Biotech Institutes is dedicated to ensuring America’s leadership in bioscience innovation by delivering industry-led life science education, workforce...

Algomedix Inc.

Algomedix Inc., a biotech company located in Mill Creek WA, and San Diego, CA, is developing potential first-in-class non-opioid medicines for chronic and acute pain. The c...

Cornerstone Search Group

Cornerstone Search Group is a Life Sciences Executive Search firm headquartered in the heart of the New Jersey "Pharmaceutical/Biotech Corridor." Established in 2000 by search ind...

Galecto Biotech AB

Galectin-3 is a member of the galectin family of galactoside binding lectins. Galectin-3 exists both intra- and extracellularly and binds to glycosylated proteins. Galectin-3 has ...

Anatara Lifesciences

Anatara Lifesciences is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach® is a natural plant based product that w...

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious dise...

MK&A

Founded in 1995, MK&A is a leading consultancy to the pharmaceutical, biotech, device and diagnostic companies around the world in their quest to deliver quality care through inno...

Platelet BioGenesis

Platelet BioGenesis is a venture-backed, development stage biotech company creating designer platelets (PLTs+™) as a new class of therapeutics. Platelet BioGenesis has develo...

SparingVision

SparingVision is a biotechnology company focused on the discovering and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

This phase IV clinical study was designed to evaluate the immunogenicity and safety of the recombinant Hepatitis E vaccine(Hecolin®), manufactured by Xiamen Innovax Biotech CO., LTD., in ...

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Fimaporfin (TPCS2a) is a photosensitiser drug being developed by PCI Biotech AS for use in novel Photochemical Internalisation (PCI) technology. PCI technology is designed to enhance the e...

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

The purpose of this study is to assess the safety and immunogenicity of three seasonal trivalent influenza vaccines (TIVs)manufactured by Glaxosmith Kline (GSK), Beijing Sinovac Biotech (S...

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

This is a bridging trial of the recombinant HPV 16/18 bivalent vaccine manufactured by Xiamen Innovax Biotech CO., LTD.The primary objective of this study is to evaluate the immunogenicity...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant ...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Pevion Biotech develops a state-of-the-art vaccine against recurrent vulvovaginal candidiasis (VVC) caused by the pathogenic form of Candida albicans especially in pre-menopausal women of ...

PubMed Articles [50 Associated PubMed Articles listed on BioPortfolio]

The ethics of access to patented biotech research tools from universities and other research institutions.

Research biotech patenting 2017.

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Short-interfering RNA (siRNA)-induced RNAi responses have great potential to treat a wide variety of human diseases from cancer to pandemic viral outbreaks to Parkinson's Disease. However, before siRN...

Solvent Tolerance in Bacteria: Fulfilling the Promise of the Biotech Era?

The challenge of sustainably producing highly valuable chemical compounds requires specialized microbial cell factories because many of these compounds can be toxic to microbial hosts. Therefore, solv...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach.

Human lemur tyrosine kinase-3 (LMTK3) is primarily involved in regulation of estrogen receptor-α (ERα) by phosphorylation activity. LMTK3 acts as key biomarker for ERα positive breast cancer and id...

Purification, developmental expression, and in silico characterization of α-amylase inhibitor from .

Barnyard () and finger () millet growing at northwestern Himalaya were explored for the α-amylase inhibitor (α-AI). The mature seeds of barnyard millet variety PRJ1 had maximum α-AI activity which ...

Bioremediation of oil-based drill cuttings by a halophilic consortium isolated from oil-contaminated saline soil.

Oil-based drill cuttings are hazardous wastes containing complex hydrocarbons, heavy metals, and brine. Their remediation is a crucial step before release to the environment. In this work, we enriched...

Exploring expression patterns of PR-1, PR-2, PR-3, and PR-12 like genes in upon inoculation.

In this study, we systematically examined the expression patterns of pathogenesis-related genes in model plant after inoculation using reverse transcription polymerase chain reaction(RT-PCR). Based...

Biosynthesis of miglitol intermediate 6-(-hydroxyethyl)-amino-6-deoxy-α-l-sorbofuranose by an improved d-sorbitol dehydrogenase from .

Adaptable exploitation of the catalytic potential of membrane-bound d-sorbitol dehydrogenase (mSLDH) from is desperately needed in the industrial-scale production of miglitol. In the present study, a...

Videos

None available.

Medical and Biotech [MESH] Definitions

None available.

Advertisement
Quick Search
Advertisement
Advertisement

 
review and buy Biotech jobs market research data and corporate reports here

Channels Quicklinks